-
Loading metrics
Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison
- Mohammed H. Al-Qahtani,
- Mourad Assidi,
- Abdelbaset Buhmeida,
- Asma Almuhammadi,
- Peter Natesan Pushparaj,
- Nofe Ateq Alganmi
x
- Published: February 13, 2026
- https://doi.org/10.1371/journal.pone.0341446